Cargando…

Listen to the public and fulfil their information interests – translating vaccine communication research findings into guidance for regulators

Regulatory authorities have a crucial role in communicating about the vaccines they license. In terms of content and timing, their communication to the public is usually driven by data on quality, safety and efficacy. However, concerns over safety and vaccine hesitancy have emerged in some communiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahri, Priya, Castillon Melero, Mireia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046478/
https://www.ncbi.nlm.nih.gov/pubmed/29573274
http://dx.doi.org/10.1111/bcp.13587
_version_ 1783339825561075712
author Bahri, Priya
Castillon Melero, Mireia
author_facet Bahri, Priya
Castillon Melero, Mireia
author_sort Bahri, Priya
collection PubMed
description Regulatory authorities have a crucial role in communicating about the vaccines they license. In terms of content and timing, their communication to the public is usually driven by data on quality, safety and efficacy. However, concerns over safety and vaccine hesitancy have emerged in some communities in various countries, and this demands a new approach to communication, starting with listening to the public debate. Reviewing communication research findings, coming in particular from the cognitive, decision‐making and media sciences, constitutes one mechanism of listening and has led the European Union (EU) regulatory network to developing guidance about which common concerns and information needs of the public to address through proactive and prepared communication. The guidance has been welcomed by EU and international fora. The current article summarizes the recommendations and shares the underlying research findings, as well as a proof of concept that communication research can be valuable for regulators. It is critical that regulators integrate the communication process with product risk assessment in the framework of pharmacovigilance, to ensure that public concerns are addressed in the assessments and that information about evidence and uncertainty relating to safety is provided to the public and vaccination policy makers in a specific, clear and accurate manner. Additionally, information from regulatory authorities should support healthcare professionals in their communication with patients. Meeting the information interests of the public is the principal prerequisite for informed decisions as well as safe and effective use of vaccines and medicines overall. This is also fundamental for trust in the authorities' commitment to patient and population health.
format Online
Article
Text
id pubmed-6046478
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-60464782018-07-16 Listen to the public and fulfil their information interests – translating vaccine communication research findings into guidance for regulators Bahri, Priya Castillon Melero, Mireia Br J Clin Pharmacol Reviews Regulatory authorities have a crucial role in communicating about the vaccines they license. In terms of content and timing, their communication to the public is usually driven by data on quality, safety and efficacy. However, concerns over safety and vaccine hesitancy have emerged in some communities in various countries, and this demands a new approach to communication, starting with listening to the public debate. Reviewing communication research findings, coming in particular from the cognitive, decision‐making and media sciences, constitutes one mechanism of listening and has led the European Union (EU) regulatory network to developing guidance about which common concerns and information needs of the public to address through proactive and prepared communication. The guidance has been welcomed by EU and international fora. The current article summarizes the recommendations and shares the underlying research findings, as well as a proof of concept that communication research can be valuable for regulators. It is critical that regulators integrate the communication process with product risk assessment in the framework of pharmacovigilance, to ensure that public concerns are addressed in the assessments and that information about evidence and uncertainty relating to safety is provided to the public and vaccination policy makers in a specific, clear and accurate manner. Additionally, information from regulatory authorities should support healthcare professionals in their communication with patients. Meeting the information interests of the public is the principal prerequisite for informed decisions as well as safe and effective use of vaccines and medicines overall. This is also fundamental for trust in the authorities' commitment to patient and population health. John Wiley and Sons Inc. 2018-05-31 2018-08 /pmc/articles/PMC6046478/ /pubmed/29573274 http://dx.doi.org/10.1111/bcp.13587 Text en © 2018 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Reviews
Bahri, Priya
Castillon Melero, Mireia
Listen to the public and fulfil their information interests – translating vaccine communication research findings into guidance for regulators
title Listen to the public and fulfil their information interests – translating vaccine communication research findings into guidance for regulators
title_full Listen to the public and fulfil their information interests – translating vaccine communication research findings into guidance for regulators
title_fullStr Listen to the public and fulfil their information interests – translating vaccine communication research findings into guidance for regulators
title_full_unstemmed Listen to the public and fulfil their information interests – translating vaccine communication research findings into guidance for regulators
title_short Listen to the public and fulfil their information interests – translating vaccine communication research findings into guidance for regulators
title_sort listen to the public and fulfil their information interests – translating vaccine communication research findings into guidance for regulators
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046478/
https://www.ncbi.nlm.nih.gov/pubmed/29573274
http://dx.doi.org/10.1111/bcp.13587
work_keys_str_mv AT bahripriya listentothepublicandfulfiltheirinformationintereststranslatingvaccinecommunicationresearchfindingsintoguidanceforregulators
AT castillonmeleromireia listentothepublicandfulfiltheirinformationintereststranslatingvaccinecommunicationresearchfindingsintoguidanceforregulators